The global bone regeneration market is on a path of remarkable growth, projected to reach a substantial valuation of US$ 7,827.8 million by 2033, as reported in a comprehensive analysis. The market is set to witness a steady Compound Annual Growth Rate (CAGR) of 3.8% from 2023 to 2033, driven by various factors that highlight the critical need for advanced bone regenerative techniques.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15486
Unprecedented Demand for Bone Graft Substitutes
In 2022, bone graft substitutes dominated the bone regeneration market with an impressive market share of 81.2%. This category of products has become a cornerstone in the field of bone regeneration due to their effectiveness in supporting reconstructive surgery and addressing the prevalence of bone diseases worldwide.
Addressing the Burden of Bone Diseases
The demand for bone regenerative solutions is steadily on the rise due to the increasing need for reconstructive surgery and the alarming prevalence of bone diseases across the globe. Shocking statistics reveal that nearly 10% of men and 18% of women over the age of 60 suffer from symptomatic osteoarthritis, underlining the significance of bone regenerative techniques.
Sports-Related Injuries on the Rise
Notably, a significant increase in bone injuries and hip fractures, particularly among sports enthusiasts, has resulted in a surge in demand for bone regeneration surgeries. The need for effective, advanced solutions to help individuals recover from such injuries and resume their active lifestyles has contributed to the growth of the bone regeneration market.
Key Players
- Medtronic plc.
- Stryker Corporation
- DePuy Synthes Inc.
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet HoldingsInc.
- Xtant Medical HoldingsInc.
- Arthrex Inc.
- Baxter International Inc.
- Musculoskeletal Transplant Foundation
- Smith & NephewInc.
- Orthofix HoldingsInc.
- NuvasiveInc.
- Allosaurus
- NovaBone ProductsLLC
- BonAlive Biomaterials Ltd.
- Sigma Graft Biomaterials
- RTI Surgical
- Institut Straumann AG
- ExactechInc
- A.B. Dental Devices Ltd
- Geistlich Pharma AG
- BMT Group
- Osstem Implant
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-15486
Key Segments
By Product:
- Bone Grafts Substitutes
- Allografts
- Demineralized Bone Matrix(DBM)
- Others
- Xenograft
- Autografts
- Synthetic Bone Graft
- Bone Morphogenetic Protein(BMP)
- Allografts
- Bone Growth Stimulators
- Non-Invasive Electrical Bone Growth Stimulators
- Invasive Electrical Bone Growth Stimulators
By Application:
- Osteoarthritis (OA)
- Osteoporosis
- Rheumatoid Arthritis (RA)
- Spinal Disorders
- Dentistry
- Craniomaxillofacial (CMF)
- Trauma Cases
By Age Group:
- Pediatric
- Adults
- Geriatric
By End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
